Home » Verify Brand, Rehrig Pacific and Intelleflex Address Calif. Board of Pharmacy
Verify Brand, Rehrig Pacific and Intelleflex Address Calif. Board of Pharmacy
Verify Brand, Rehrig Pacific Co. and Intelleflex
Scott Pugh of Verify Brand, Kaley Parkinson of Rehrig Pacific Company and Peter Norton of Intelleflex delivered a presentation that focused on the benefits of an integrated approach that combines powerful RFID capabilities with track-and-trace software solutions and intelligent reusable transport items. This approach would:
· Provide an e-Pedigree that meets evolving government-mandated regulatory requirements using a flexible solution that can grow and change with the application in use to prevent disruption due to upgrades and version changes.
· Provide a secure, safe, regulatory compliant and efficient method for track-and-trace throughout the supply chain while maintaining closed loop data and providing a source of data retention for applications where the closed loop becomes open distribution.
· Deliver an efficient way to read product serial numbers, ownership and condition data immediately upon receipt and without opening or disturbing the packaging — thereby providing a suitable replacement for 2D and 1D barcodes for monitoring units in cartons or on pallets.
The integrated approach presented to the Board of Pharmacy overcomes the limitations of 1D and 2D barcodes, which are static and cannot be updated as products move through distribution. The presenters showed that Battery Assisted Passive RFID tags, in conjunction with cloud-based software-as-a-service traceability solutions and intelligent returnable transport items (such as RFID-equipped plastic containers and pallets) can securely record the chain of custody data and any changes of content data at any point in the distribution cycle. This approach can aid in anti-counterfeiting and reduces the diversion of high-value drugs and temperature-sensitive biologics. It also provides an efficient method of high-quality data capture and content monitoring with the flexibility to meet changes to regulations and application upgrades.
“The real value for the e-Pedigree investments being made will not only increase consumer confidence, but at the same time reduce the time and cost for recovery,” said Ann Grackin, CEO of ChainLink Research. “Companies can leverage investments in RFID, track-and-trace applications and returnable transport items to provide real-time responsive supply chain management. This information can address a variety of benefits from better inventory position, cost containment, and product locating to assure customer service, safe product dispensing, to name a few.”
The presenters noted that data can be stored securely on Battery Assisted Passive tags to provide a chain-of-custody record (an RFID e-Pedigree) and a record of the aggregated individual unit serial numbers – all within the tag's memory securely to further enhance their usability in this environment. The same approach ensures that, even at the last point of the distribution chain, the authenticity of the product can be validated by reading the tag and matching its contents with those of the product’s manifest. The presenters also showed that Battery-assisted Passive RFID tags can wirelessly monitor the temperature and condition of products inside cartons or containers – without requiring unpacking of their contents – to help reduce temperature excursions (variances), while ensuring the security and authenticity of the products inside the package.
“Providing pharmaceutical manufacturers with a method to serialize with random unique identifiers efficiently and track product easily is essential to building a secure supply chain,” said Kevin Erdman, President of Verify Brand. “Additionally, enabling product authentication throughout the supply chain via mobile and Web applications increases manufacturers ROI from serialization efforts while meeting regulatory compliance and mitigating risk of counterfeit product from entering the supply chain.”
“Using a solution that leverages the value of Intelligent Reusables that already exist in the pharmaceutical supply chain only makes sense,” said Kaley Parkinson, National Sales Manager at Rehrig Pacific. “Reinventing a different, secondary alternative solution only adds cost and barriers to the rapidly approaching implementation deadline. Pairing a regulatory solution with a safer way to get medicines and biologics through the supply chain lowers implementation costs and improves patient safety at the same time.”
“New e-Pedigree regulations will require pharmaceutical manufacturers, distributors and logistics providers to redefine their cold supply chains, and traceability processes, said Peter Mehring, President and CEO of Intelleflex. “SaaS-based solutions, intelligent RTIs with embedded temperature monitors, and cloud-based data services like ZEST, will enable the cold chain to proactively address the new cold chain dynamics for serialization and potentially provide a solution for inference adoption.”
A video of the presentation can be found at: http://www.youtube.com/watch?v=064DdbZvnZw
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
- All news »